Dr Sanil Rege

February 19, 2020

Time to read: 4 minutes

Depression occurs commonly in schizophrenia and first-episode psychosis (FEP) and challenges the Kraepelinian Dichotomy betwe...

 Dr Sanil Rege

February 17, 2020

Time to read: 8 minutes

The National Institute of Mental Health-sponsored Sequenced Treatment Alternatives to Relieve Depression (STAR*D) showed that approximately 30% of MDD p...

 Dr Sanil Rege, Dr James Graham

February 13, 2020

Time to read: 8 minutes

Physical activity is recommended in clinical practice as a viable intervention for the treatment of subthreshold, mild, and moderate depression. Researc...

 Dr Sanil Rege

February 5, 2020

Time to read: 14–16 minutes

Depression affects up to 350 million people around the world, but response rates to a first-line antidepressant can be as low as 50%. ...

Dr Sanil Rege talks with Prof Martin Katzman, an expert in the field of mood and anxiety disorders. Professor Martin Katzman is the Clinic Direct...

September 9, 2019

Time to read: 2 minutes

This article is based on the talk by Prof Allan Young at RCPsychIC 2019. He is Chair of Mood Disorders, Director of the Centre for Affective Disorders i...

 Dr Sanil Rege, Dr James Graham

August 29, 2019

Time to read: 9 minutes

Throughout the history of medicine, thousands of drugs have been developed, but only one has been influential enough to earn the title o...

 Dr Sanil Rege, Dr James Graham

August 26, 2019

Time to read: 4 minutes

Lamotrigine is a synthetic phenyltriazine drug with analgesic and antiepileptic properties. It is primarily used as an anticonvulsant for the adjunctive...

August 14, 2019

Time to read: 3 minutes

This summary is based on Prof Robin Murray’s talk at the RCPsych IC 2019. 1. Many patients diagnosed with treatment-resistant schizophrenia...

Dr. Sanil Rege is a Consultant Psychiatrist and founder of Psych Scene...